Download MendeleyThe structure of NS-398 bound to cyclooxygenase-2.
Vecchio, A.J., Malkowski, M.G.(2011) J Struct Biol 176: 254-258
- PubMed: 21843643 Search on PubMedSearch on PubMed Central
- DOI: https://doi.org/10.1016/j.jsb.2011.07.019
- Primary Citation Related Structures:
3QMO - PubMed Abstract:
The cyclooxygenases (COX-1 and COX-2) are membrane-associated, heme-containing homodimers that generate prostaglandin H(2) from arachidonic acid (AA) in the committed step of prostaglandin biogenesis and are the targets for nonsteroidal anti-inflammatory drugs (NSAIDs). N-(2-cyclohexyloxy-4-nitrophenyl) methanesulfonamide (NS-398) was the first in a series of isoform-selective drugs designed to preferentially inhibit COX-2, with the aim of ameliorating many of the toxic gastrointestinal side effects caused by conventional NSAID inhibition. We determined the X-ray crystal structure of murine COX-2 in complex with NS-398 utilizing synchrotron radiation to 3.0A resolution. NS-398 binds in the cyclooxygenase channel in a conformation that is different than that observed for other COX-2-selective inhibitors, such as celecoxib, with no discernible penetration into the side pocket formed in COX-2 by the isoform-specific substitutions of I434V, H513R, and I523V. Instead, the methanesulfonamide moiety of NS-398 interacts with the side chain of Arg-120 at the opening of the cyclooxygenase channel, similar to that observed for acidic, nonselective NSAIDs such as indomethacin and flurbiprofen. Our structure validates inhibitor studies that identified Arg-120 as a molecular determinant for time-dependent inhibition of COX-2 by NS-398.
- Hauptman-Woodward Medical Research Institute, The State University of New York at Buffalo, 700 Ellicott Street, Buffalo, NY 14203, USA.
Organizational Affiliation:
